
Photo from ESTRO/X
Jul 10, 2024, 06:47
The latest results from the PACE-C trial presented at ESTRO24
ESTRO (European SocieTy for Radiotherapy and Oncology) shared a post on X: .
“Check out the latest results from the PACE-C trial that were presented at ESTRO24, comparing SBRT and MHRT for high-risk prostate cancer with ADT.”
Source: ESTRO/X
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Mar 20, 2025, 17:47
Mar 20, 2025, 17:37
Mar 20, 2025, 17:29
Mar 20, 2025, 16:59
Mar 20, 2025, 15:17